Registry of Subjects at Risk of Pancreatic Cancer

ConditionsFamilial Pancreatic Cancer BRCA1 Mutation BRCA2 Mutation Lynch Syndrome FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome Hereditary Pancreatitis Peutz-Jeghers Syndrome

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-80

SponsorAssociazione Italiana per lo Studio del Pancreas

About this trial

IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.

Eligibility criteria

Qualifiers

individuals with at least two relatives suffering from pancreatic cancer, with at least 1 first-degree and until the third-degree

subjects with known genetic mutation of BRCA2, BRCA1, p16, PALB2 with at least 1 first- or 2nd-degree relative suffering from pancreatic cancer

subjects suffering from FAMMM Syndrome

subjects suffering from Peutz-Jeghers Syndrome

Disqualifiers

None

Trial design

Treatments tested in this trial

MRCP
Endoultrasonography

Treatment groups

1,000 Participants

are divided into 6 treatment groups

Treatment groups

See each treatment group below.

Locations

Istituto Clinico Humanitas RozzanoMilan, Italy

Ospedale Pederzoli Peschiera del GardaVerona, Italy

San Raffele Vita Salute University Hospital Milan Italy

Chirurgia Generale e del Pancreas37134, Verona Italy

Sponsors and collaborators

Associazione Italiana per lo Studio del Pancreas

Lead sponsor

Source ClinicalTrials.gov